JPS6111935B2 - - Google Patents

Info

Publication number
JPS6111935B2
JPS6111935B2 JP55050725A JP5072580A JPS6111935B2 JP S6111935 B2 JPS6111935 B2 JP S6111935B2 JP 55050725 A JP55050725 A JP 55050725A JP 5072580 A JP5072580 A JP 5072580A JP S6111935 B2 JPS6111935 B2 JP S6111935B2
Authority
JP
Japan
Prior art keywords
compound
general formula
solution
added
pepsin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55050725A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56147718A (en
Inventor
Shinichi Kojima
Yasushi Koide
Shigeo Ogino
Toshiro Tsucha
Yoshito Kameno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Priority to JP5072580A priority Critical patent/JPS56147718A/ja
Priority to AU68597/81A priority patent/AU540224B2/en
Priority to EP81301314A priority patent/EP0038132B1/en
Priority to DE8181301314T priority patent/DE3161155D1/de
Priority to AT81301314T priority patent/ATE4978T1/de
Priority to CA000374189A priority patent/CA1151643A/en
Priority to US06/249,984 priority patent/US4348386A/en
Priority to MX10157681U priority patent/MX6239E/es
Priority to DK164581A priority patent/DK164581A/da
Priority to HU81974A priority patent/HU185253B/hu
Priority to ES501405A priority patent/ES8203831A1/es
Publication of JPS56147718A publication Critical patent/JPS56147718A/ja
Publication of JPS6111935B2 publication Critical patent/JPS6111935B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
JP5072580A 1980-04-16 1980-04-16 Acidic protease inhibitor and antiulcerative composed thereof Granted JPS56147718A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP5072580A JPS56147718A (en) 1980-04-16 1980-04-16 Acidic protease inhibitor and antiulcerative composed thereof
AU68597/81A AU540224B2 (en) 1980-04-16 1981-03-20 Protease inhibitors
EP81301314A EP0038132B1 (en) 1980-04-16 1981-03-26 Process for preparing protease inhibitors
DE8181301314T DE3161155D1 (en) 1980-04-16 1981-03-26 Process for preparing protease inhibitors
AT81301314T ATE4978T1 (de) 1980-04-16 1981-03-26 Verfahren zur herstellung von hemmungsmitteln fuer protease.
CA000374189A CA1151643A (en) 1980-04-16 1981-03-30 Protease inhibitors
US06/249,984 US4348386A (en) 1980-04-16 1981-04-01 Protease inhibitors
MX10157681U MX6239E (es) 1980-04-16 1981-04-08 Procedimiento para producir inhibidores acidos de proteasa
DK164581A DK164581A (da) 1980-04-16 1981-04-10 Fremgangsmaade til fremstilling af surproteaseinhibitor
HU81974A HU185253B (en) 1980-04-16 1981-04-14 Process for preparing protease inhibitors
ES501405A ES8203831A1 (es) 1980-04-16 1981-04-15 Un procedimiento para obtener un inhibidor de proteasa acida

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5072580A JPS56147718A (en) 1980-04-16 1980-04-16 Acidic protease inhibitor and antiulcerative composed thereof

Publications (2)

Publication Number Publication Date
JPS56147718A JPS56147718A (en) 1981-11-16
JPS6111935B2 true JPS6111935B2 (en, 2012) 1986-04-05

Family

ID=12866832

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5072580A Granted JPS56147718A (en) 1980-04-16 1980-04-16 Acidic protease inhibitor and antiulcerative composed thereof

Country Status (10)

Country Link
US (1) US4348386A (en, 2012)
EP (1) EP0038132B1 (en, 2012)
JP (1) JPS56147718A (en, 2012)
AT (1) ATE4978T1 (en, 2012)
AU (1) AU540224B2 (en, 2012)
CA (1) CA1151643A (en, 2012)
DE (1) DE3161155D1 (en, 2012)
DK (1) DK164581A (en, 2012)
ES (1) ES8203831A1 (en, 2012)
HU (1) HU185253B (en, 2012)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.
US4866040A (en) * 1986-01-06 1989-09-12 Alfred Stracher Aminocarnitine directed pharmaceutical agents
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
US6706280B2 (en) * 1998-08-19 2004-03-16 Bracco Research S.A. Carboxylated phosphatidic acid esters

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840516A (en) * 1969-06-13 1974-10-08 Microbial Chem Res Found Biologically active substance,pepstatin and production processes thereof
JPS5625315B2 (en, 2012) * 1973-11-15 1981-06-11
US4050989A (en) * 1974-12-05 1977-09-27 Eisai Co., Ltd. Process of preparing desacyl-pepsidine with bacillus pumilus
DE2640420C2 (de) * 1975-09-12 1985-01-10 Sumitomo Chemical Co., Ltd., Osaka Als Procidine bezeichnete Peptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel

Also Published As

Publication number Publication date
AU540224B2 (en) 1984-11-08
ATE4978T1 (de) 1983-10-15
HU185253B (en) 1984-12-28
EP0038132B1 (en) 1983-10-12
ES501405A0 (es) 1982-04-01
DE3161155D1 (en) 1983-11-17
JPS56147718A (en) 1981-11-16
CA1151643A (en) 1983-08-09
AU6859781A (en) 1981-10-22
ES8203831A1 (es) 1982-04-01
EP0038132A3 (en) 1982-03-17
US4348386A (en) 1982-09-07
DK164581A (da) 1981-10-17
EP0038132A2 (en) 1981-10-21

Similar Documents

Publication Publication Date Title
JPS58135870A (ja) チアゾ−ル誘導体、その製造法およびそれを有効成分とする医薬
PL159180B1 (pl) [/Z/-2-/2-aminotiazolilo-4/ -4-karboksybuten-2-oiloamino]-3- cefemokarboksylowego-4 PL PL PL
RU2344083C2 (ru) Адсорбент фосфата на основе сульфата железа
RU2039060C1 (ru) Хелатные комплексы азитромицина
RU2228331C2 (ru) Нитратные соли гетероциклических соединений, способ их получения и фармацевтические композиции на их основе
JPS6229566A (ja) 新規グアニジノメチル安息香酸誘導体
JPS6111935B2 (en, 2012)
RU2003134076A (ru) Клатрат гидрата азитромицина с 1,2,-пропиленгликолем, способ его получения и содержащая его фармацевтическая композиция
US4455305A (en) Composition for the treatment of colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronic nonspecific colitis and diverticulitis and the use of salicylazobenzoic acid for the preparation of such compositions
US4935406A (en) Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
PT97487A (pt) Processo para a preparacao de sais de derivados de furano e de um complexo de bismuto com um acido carboxilico terapeuticamente uteis
US4076815A (en) Quinoxaline compound and composition, process for preparing compound, and method of combatting cholera therewith
KR850001133B1 (ko) 항펩신제의 제조방법
JP3348849B2 (ja) ３−ヒドロキシ−４−ピロンのガリウム錯体の医薬組成物
JPS6323174B2 (en, 2012)
US6060498A (en) Composition containing antitumor agent
US4918175A (en) Bismuth (phosph/sulf)ated saccharides
US5292943A (en) Method for the preparation of low odor 2,3-dimercaptosuccinic acid
JPS6016997A (ja) オピオイド分解酵素阻害剤
SU734194A1 (ru) 3-Метокси-4-окси-5-( -дикарбоксиметил)-аминометилбензофенон в качестве комплексообразующего вещества
JPS5929692A (ja) 結晶性ナトリウムセホペラゾンの製造方法
US2516831A (en) Arsine derivatives
SU1340077A1 (ru) Гидрохлорид 7-бром-2-амино-3Н-3-оксофенотиазина обладающий противотуберкулезной активностью
US3082253A (en) Complexes of tetracycline antibiotics and preparation of same
JPS58157776A (ja) 結晶状サツカリンカルシウムの調製法